Back to Rockefeller Capital Management L.P. Rockefeller Capital Management L.P.

QNCXQNCX

Showing 2 of 6 quarters

Position history for Rockefeller Capital Management L.P.Rockefeller Capital Management L.P.'s holdings in QUINCE THERAPEUTICS INC

No. Rockefeller Capital Management exited its QNCX (Quince Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 169,554 shares worth $279,764. Rockefeller Capital Management first reported QNCX in Q1 2021 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$279,764

Total Shares Change

-169,554

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$326.00
0
2025-Q2
New
169,554
—
$279,7640.0%$330.00
32

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used